Asymptomatic SARS-CoV-2 seropositivity: patients with childhood-onset rheumatic diseases versus healthy children

MLA

Haslak, Fatih, et al. “Asymptomatic SARS-CoV-2 Seropositivity: Patients with Childhood-Onset Rheumatic Diseases versus Healthy Children.” Clinical Rheumatology, vol. 41, Jan. 2022, pp. 1523–33. EBSCOhost, https://doi.org/10.1007/s10067-022-06067-5.

APA

Haslak, F., Ozbey, D., Yildiz, M., Adrovic, A., Sahin, S., Koker, O., Aliyeva, A., Guliyeva, V., Yalcin, G., Inanli, G., Kocazeybek, B. S., Kasapcopur, O., & Barut, K. (2022). Asymptomatic SARS-CoV-2 seropositivity: patients with childhood-onset rheumatic diseases versus healthy children. Clinical Rheumatology, 41, 1523–1533. https://doi.org/10.1007/s10067-022-06067-5

Chicago

Haslak, Fatih, Dogukan Ozbey, Mehmet Yildiz, Amra Adrovic, Sezgin Sahin, Oya Koker, Ayten Aliyeva, et al. 2022. “Asymptomatic SARS-CoV-2 Seropositivity: Patients with Childhood-Onset Rheumatic Diseases versus Healthy Children.” Clinical Rheumatology 41 (January): 1523–33. doi:10.1007/s10067-022-06067-5.